-
Je něco špatně v tomto záznamu ?
Synthesis, 18F-labelling and radiopharmacological characterisation of the C-terminal 30mer of Clostridium perfringens enterotoxin as a potential claudin-targeting peptide
R. Löser, M. Bader, M. Kuchar, R. Wodtke, J. Lenk, J. Wodtke, K. Kuhne, R. Bergmann, C. Haase-Kohn, M. Urbanová, J. Steinbach, J. Pietzsch,
Jazyk angličtina Země Rakousko
Typ dokumentu časopisecké články
NLK
ProQuest Central
od 1997-03-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2010-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-03-01 do Před 1 rokem
Springer Nature OA/Free Journals
od 1991-02-01
- MeSH
- buňky HT-29 MeSH
- cílená molekulární terapie MeSH
- claudin-4 antagonisté a inhibitory chemie metabolismus MeSH
- enterotoxiny chemická syntéza chemie farmakokinetika farmakologie MeSH
- izotopové značení MeSH
- krysa rodu rattus MeSH
- lidé MeSH
- ligandy MeSH
- molekulární mimikry fyziologie MeSH
- molekulární zobrazování MeSH
- myši nahé MeSH
- myši MeSH
- nádory farmakoterapie MeSH
- potkani Wistar MeSH
- pozitronová emisní tomografie MeSH
- radioizotopy fluoru chemie MeSH
- techniky syntézy na pevné fázi MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- lidé MeSH
- mužské pohlaví MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
The cell surface receptor claudin-4 (Cld-4) is upregulated in various tumours and represents an important emerging target for both diagnosis and treatment of solid tumours of epithelial origin. The C-terminal fragment of the Clostridium perfringens enterotoxin cCPE290-319 appears as a suitable ligand for targeting Cld-4. The synthesis of this 30mer peptide was attempted via several approaches, which has revealed sequential SPPS using three pseudoproline dipeptide building blocks to be the most efficient one. Labelling with fluorine-18 was achieved on solid phase using N-succinimidyl 4-[18F]fluorobenzoate ([18F]SFB) and 4-[18F]fluorobenzoyl chloride as 18F-acylating agents, which was the most advantageous when [18F]SFB was reacted with the resin-bound 30mer containing an N-terminal 6-aminohexanoic spacer. Binding to Cld-4 was demonstrated via surface plasmon resonance using a protein construct containing both extracellular loops of Cld-4. In addition, cell binding experiments were performed for 18F-labelled cCPE290-319 with the Cld-4 expressing tumour cell lines HT-29 and A431 that were complemented by fluorescence microscopy studies using the corresponding fluorescein isothiocyanate-conjugated peptide. The 30mer peptide proved to be sufficiently stable in blood plasma. Studying the in vivo behaviour of 18F-labelled cCPE290-319 in healthy mice and rats by dynamic PET imaging and radiometabolite analyses has revealed that the peptide is subject to substantial liver uptake and rapid metabolic degradation in vivo, which limits its suitability as imaging probe for tumour-associated Cld-4.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028185
- 003
- CZ-PrNML
- 005
- 20190816102901.0
- 007
- ta
- 008
- 190813s2019 au f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00726-018-2657-9 $2 doi
- 035 __
- $a (PubMed)30264172
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a au
- 100 1_
- $a Löser, Reik $u Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany. r.loeser@hzdr.de. Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, Mommsenstraße 4, 01062, Dresden, Germany. r.loeser@hzdr.de.
- 245 10
- $a Synthesis, 18F-labelling and radiopharmacological characterisation of the C-terminal 30mer of Clostridium perfringens enterotoxin as a potential claudin-targeting peptide / $c R. Löser, M. Bader, M. Kuchar, R. Wodtke, J. Lenk, J. Wodtke, K. Kuhne, R. Bergmann, C. Haase-Kohn, M. Urbanová, J. Steinbach, J. Pietzsch,
- 520 9_
- $a The cell surface receptor claudin-4 (Cld-4) is upregulated in various tumours and represents an important emerging target for both diagnosis and treatment of solid tumours of epithelial origin. The C-terminal fragment of the Clostridium perfringens enterotoxin cCPE290-319 appears as a suitable ligand for targeting Cld-4. The synthesis of this 30mer peptide was attempted via several approaches, which has revealed sequential SPPS using three pseudoproline dipeptide building blocks to be the most efficient one. Labelling with fluorine-18 was achieved on solid phase using N-succinimidyl 4-[18F]fluorobenzoate ([18F]SFB) and 4-[18F]fluorobenzoyl chloride as 18F-acylating agents, which was the most advantageous when [18F]SFB was reacted with the resin-bound 30mer containing an N-terminal 6-aminohexanoic spacer. Binding to Cld-4 was demonstrated via surface plasmon resonance using a protein construct containing both extracellular loops of Cld-4. In addition, cell binding experiments were performed for 18F-labelled cCPE290-319 with the Cld-4 expressing tumour cell lines HT-29 and A431 that were complemented by fluorescence microscopy studies using the corresponding fluorescein isothiocyanate-conjugated peptide. The 30mer peptide proved to be sufficiently stable in blood plasma. Studying the in vivo behaviour of 18F-labelled cCPE290-319 in healthy mice and rats by dynamic PET imaging and radiometabolite analyses has revealed that the peptide is subject to substantial liver uptake and rapid metabolic degradation in vivo, which limits its suitability as imaging probe for tumour-associated Cld-4.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a claudin-4 $x antagonisté a inhibitory $x chemie $x metabolismus $7 D062506
- 650 _2
- $a enterotoxiny $x chemická syntéza $x chemie $x farmakokinetika $x farmakologie $7 D004768
- 650 _2
- $a radioizotopy fluoru $x chemie $7 D005462
- 650 _2
- $a buňky HT-29 $7 D019073
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a izotopové značení $7 D007553
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši nahé $7 D008819
- 650 _2
- $a molekulární zobrazování $7 D057054
- 650 _2
- $a molekulární mimikry $x fyziologie $7 D018716
- 650 _2
- $a cílená molekulární terapie $7 D058990
- 650 _2
- $a nádory $x farmakoterapie $7 D009369
- 650 _2
- $a pozitronová emisní tomografie $7 D049268
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a techniky syntézy na pevné fázi $7 D060327
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bader, Miriam $u Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany. Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, Mommsenstraße 4, 01062, Dresden, Germany.
- 700 1_
- $a Kuchar, Manuela $u Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany. Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, Mommsenstraße 4, 01062, Dresden, Germany.
- 700 1_
- $a Wodtke, Robert $u Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany. Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, Mommsenstraße 4, 01062, Dresden, Germany.
- 700 1_
- $a Lenk, Jens $u Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany. Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, Mommsenstraße 4, 01062, Dresden, Germany.
- 700 1_
- $a Wodtke, Johanna $u Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany.
- 700 1_
- $a Kuhne, Konstantin $u Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany. Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, Mommsenstraße 4, 01062, Dresden, Germany.
- 700 1_
- $a Bergmann, Ralf $u Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany.
- 700 1_
- $a Haase-Kohn, Cathleen $u Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany.
- 700 1_
- $a Urbanová, Marie $u Department of Physics and Measurements, University of Chemistry and Technology, 166 28, Prague, Czech Republic.
- 700 1_
- $a Steinbach, Jörg $u Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany. Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, Mommsenstraße 4, 01062, Dresden, Germany.
- 700 1_
- $a Pietzsch, Jens $u Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden Rossendorf, Bautzner Landstraße 400, 01328, Dresden, Germany. Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, Mommsenstraße 4, 01062, Dresden, Germany.
- 773 0_
- $w MED00000316 $t Amino acids $x 1438-2199 $g Roč. 51, č. 2 (2019), s. 219-244
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30264172 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190816103131 $b ABA008
- 999 __
- $a ok $b bmc $g 1433334 $s 1066645
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 51 $c 2 $d 219-244 $e 20180927 $i 1438-2199 $m Amino acids $n Amino Acids $x MED00000316
- LZP __
- $a Pubmed-20190813